Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Cancers
|
June 26, 2026
The Imipridone ONC206 Inhibits Tumor Growth and Improves Survival in Patient-Derived Xenograft Models of Uveal Melanoma
Mir Mustafa Ali, Md Alauddin, Iqbal Mahmud, et al.
The American Journal of Pathology
|
October 31, 2024
Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization
Lili Huang, Jingbo Yang, Jinjin Zhu, et al.
Science Advances
|
January 15, 2025
Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells
Yeye Guo, Huaishan Wang, Shujing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2025
Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas
Yunyan Li, Ziyang Cui, Xiaole Song, et al.
Iscience
|
February 18, 2026
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment
Vito W Rebecca, Min Xiao, Andrew Kossenkov, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance
Haiyin Li, Yeqing Chen, Jessica Kaster, et al.
Nature Communications
|
January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier, Michael C Brown, Gao Zhang, et al.
Nature
|
July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells
Yogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.
Cell Reports
|
June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations
Konstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Cancers
|
June 26, 2026
The Imipridone ONC206 Inhibits Tumor Growth and Improves Survival in Patient-Derived Xenograft Models of Uveal Melanoma
Mir Mustafa Ali, Md Alauddin, Iqbal Mahmud, et al.
The American Journal of Pathology
|
October 31, 2024
Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization
Lili Huang, Jingbo Yang, Jinjin Zhu, et al.
Science Advances
|
January 15, 2025
Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells
Yeye Guo, Huaishan Wang, Shujing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2025
Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas
Yunyan Li, Ziyang Cui, Xiaole Song, et al.
Iscience
|
February 18, 2026
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment
Vito W Rebecca, Min Xiao, Andrew Kossenkov, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance
Haiyin Li, Yeqing Chen, Jessica Kaster, et al.
Nature Communications
|
January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier, Michael C Brown, Gao Zhang, et al.
Nature
|
July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells
Yogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.
Cell Reports
|
June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations
Konstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.
Page
of 8